Applied Biosystems Invests $3M in Genomica, Signs Licensing Agreement | GenomeWeb

NEW YORK, Sept 6 - Applied Biosystems (NYSE: PEB) said on Wednesday it had agreed to make a $3 million equity investment in software developer Genomica.

The companies also signed an agreement under which Genomica will license its genetic-analysis object model to Applied Biosystems.

The object model will allow Applied Biosystems to store genotyping results garnered from its various instruments in a common Oracle database. Genomica's bioinformatics software products could then be used to access the genotyping results for scientific analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."